Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present at the Plant Biology 2019 Conference
August 01 2019 - 8:30AM
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience
company that uses its “Trait Factory” to develop high value seed
traits for the agriculture and food industries, today announced
that Kristi Snell, Ph.D., Yield10’s chief science officer, will
present at the Plant Biology 2019 conference, the annual meeting of
the American Society of Plant Biologists (ASPB). The
conference is being held August 3-7 in San Jose, California.
At the Plant Biology 2019 Conference, Dr. Snell will serve as
Chair for “Concurrent Symposium 20: Edited for Content” session,
which is scheduled from 3:15 pm to 5:00 pm local time on Monday,
August 5. Dr. Snell will moderate this session and present a talk
titled “Genome editing to increase seed yield and oil content.” In
the presentation, Dr. Snell will discuss strategies the Yield10
team has employed to identify and edit novel gene targets using
CRISPR genome editing to improve seed yield and oil content in
oilseed crops.
At the conference, Dr. Snell will also participate as a panelist
in a workshop titled “Commercialization in Plant Science” being
held Sunday, August 4, at 11:30am local time. Dr. Snell will also
present a poster prepared by researchers at Yield10 and Yield10’s
wholly owned subsidiary Metabolix Oilseeds titled “Identifying
genome editing targets: Using metabolism to rationally mine
genomics data.” The poster sessions are scheduled for August
4-6.
“The 'Edited for Content' session within the Plant Biology 2019
conference will provide an excellent venue for showcasing the
breadth of CRISPR genome editing research ongoing within industry
and academia and how editing is being deployed to drive
improvements in yield performance, pest resistance and nutritional
profiles in plants,” said Dr. Snell, Ph.D., Chief Science Officer
of Yield10 Bioscience. “Our presentation and poster will highlight
some of our recent progress in genome editing of oilseeds to
increase oil content, and will discuss how our novel GRAIN
computational platform takes a different approach for gene target
identification by using metabolism as a starting point to mine
genomics data to identify novel gene
targets.”
On August 5, a copy of Dr. Snell’s slide deck as well as the
conference poster will be available on the Yield10 Bioscience
investor relations
website.
About Yield10
Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company
which uses its “Trait Factory” to develop high value seed traits
for the agriculture and food industries to achieve step-change
improvements in crop yield to enhance global food security and
develop specialty crop products. Yield10 has an extensive track
record of innovation based around optimizing the flow of carbon in
living systems. The “Trait Factory” has two components: the “GRAIN”
computational modeling platform, which is used to identify specific
gene changes designed to improve crop performance, and the
deployment of those changes into crops using genome-editing or
traditional agricultural biotechnology approaches. The purpose of
the “Trait Factory” is to engineer precise alterations to gene
activity and the flow of carbon in plants to produce higher yields
with lower inputs of land, water or fertilizer. Yield10 is
advancing several yield traits it has developed in crops such as
canola, soybean, rice, wheat and corn. Yield10 is headquartered in
Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon,
Canada.
For more information about the Company, please visit the website
and follow the Company on Twitter and LinkedIn.
(YTEN-G)
Safe Harbor for Forward-Looking
Statements
This press release contains forward-looking statements which are
made pursuant to the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future
performance. Investors are cautioned that statements in this press
release which are not strictly historical, including, without
limitation, that the GRAIN computational platform may be able to
mine genomics data to identify novel gene targets, that the
Company’s seed traits may achieve step-change improvements in crop
yield and that the Company will enable the development of specialty
crop products, constitute forward-looking
statements. Such forward-looking statements are subject to a number
of risks and uncertainties that could cause actual results to
differ materially from those anticipated, including the risks and
uncertainties detailed in Yield10 Bioscience's filings with the
Securities and Exchange Commission. Yield10 assumes no obligation
to update any forward-looking information contained in this press
release or with respect to the matters described herein.
Contacts: Yield10
Bioscience:Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations: Bret Shapiro, (561) 479-8566,
brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund, eric@fischtankpr.com FischTank
Marketing and PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Apr 2023 to Apr 2024